000
| 01702nam##2200277za#4500 |
---|
001 | 9.647224 |
---|
003 | CaOODSP |
---|
005 | 20200330140426 |
---|
007 | ta |
---|
008 | 150407|1998||||xxc||||| f|0| 0 eng|d |
---|
020 | |a0-662-27482-2 |
---|
040 | |aCaOODSP|beng |
---|
043 | |an-cn--- |
---|
086 | 1 |aRG79-4/1-1998E |
---|
110 | 1 |aCanada. |bPatented Medicine Prices Review Board. |
---|
245 | 10|aRoad map for the next decade : |breport on the PMPRB's public consultations |
---|
260 | |aOttawa - Ontario : |bPatented Medicine Prices Review Board |c1998. |
---|
300 | |a34p. in various pagings. : |bgraphs, tables ; |c28 cm. |
---|
500 | |aContents: Message from the Board.--Context.--What stakeholders are saying about Canada's pharmaceutical policy and the PMPRB's mandate.--What stakeholders are saying about how the Board carries out its mandate.--Action plan for follow-up on issues raised by stakeholders.--Conclusion.--Appendices. Accompanied by: Highlights.--Consultation policy.--PMPRB research agenda: 1998-2000.--PMPRB Study series S-9811: Trends in patented veterinary medicine prices. drug prices.--U.S. prices: preliminary outline of issues.--Notice and comment: regulating patented veterinary medicine prices. Department of Veterans Affairs formulary.--Price review process: preliminary outline of issues.--Category 3 drug prices: preliminary outline of issues.--Notice and comment: regulating patented veterinary medicine prices. |
---|
563 | |aSoftcover |
---|
590 | |a99-01|b1999-01-08 |
---|
690 | 07|aDrugs|2gcpds |
---|
690 | 07|aPatents|2gcpds |
---|
690 | 07|aPrices|2gcpds |
---|
775 | 08|tLe guide pour la prochaine décennie : |w(CaOODSP)9.680649 |
---|
776 | 0#|tRoad map for the next decade : |w(CaOODSP)9.698387 |
---|